In the CNS, astrocytes, oligodendrocytes and microglias are involved in not only development but also pathology such as spinal cord injury (SCI). Glial cells play dual roles (negative vs. positive effects) in these processes. After SCI, detrimental effects usually dominate and significantly retard functional recovery, and curbing these effects is critical for promoting neurological improvement. Bone marrow stromal cells (BMSCs) represent a new therapeutic approach for SCI by enabling improved sensory and motor functions in animal models. Although transdifferentiation to spinal neurons was poor, because of their pleiotropic nature, the protective effects of BMSCs are broad and are primarily mediated through modulation of transdifferentiation into host spinal glial components. Transplantation of BMSCs can positively alter the spinal microenvironment and enhance recovery. The objective of this review is to discuss these and other related mechanisms. Since BMSCs transplantation has been applied in other clinical fields, we hope to provide useful clues for the clinical application of BMSCs to treat the SCI in the near future.
AbramsMBDominguezCPernoldKRegerRWiesenfeld-HallinZOlsonL, and others. 2009. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. Restor Neurol Neurosci27(4):307–21.
2.
AkiyamaYRadtkeCKocsisJD. 2002. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci22(15):6623–30.
3.
AnkenyDPMcTigueDMJakemanLB. 2004. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol. 190(1):17–31.
4.
BanDXNingGZFengSQWangYZhouXHLiuY, and others. 2011. Combination of activated Schwann cells with bone mesenchymal stem cells: the best cell strategy for repair after spinal cord injury in rats. Regen Med6(6):707–20.
5.
BartholomewASturgeonCSiatskasMFerrerKMcIntoshKPatilS, and others. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol30(1):42–8.
6.
BeattieMSFarooquiAABresnahanJC. 2000. Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma17(10):915–25.
7.
BoidoMGarbossaDFontanellaMDucatiAVercelliA. 2014. Mesenchymal stem cell transplantation reduces glial cyst and improves functional outcome after spinal cord compression. World Neurosurg81(1):183–90.
8.
BuffoARolandoCCerutiS. 2010. Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol79(2):77–89.
9.
BurtRKLohYCohenBStefoskiDBalabanovRKatsamakisG, and others. 2009. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol8(3):244–53.
10.
CantinieauxDQuertainmontRBlacherSRossiLWanetTNoelA, and others. 2013. Conditioned medium from bone marrow–derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PLoS One8(8):e69515.
11.
ChanCC. 2008. Inflammation: beneficial or detrimental after spinal cord injury?Recent Pat CNS Drug Discov. 3(3):189–99.
12.
ChenGWangYXuZFangFXuRWangY, and others. 2013. Neural stem cell-like cells derived from autologous bone mesenchymalstem cells for the treatment of patients with cerebral palsy. J Transl Med11:21.
13.
ChoiJSLeemJWLeeKHKimSSSuh-KimHJungSJ, and others. 2012. Effects of human mesenchymal stem cell transplantation combined with polymer on functional recovery following spinal cord hemisection in rats. Korean J Physiol Pharmacol16(6):405–11.
14.
CizkovaDRosochaJVanickyIJergovaSCizekM. 2006. Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol26(7-8);1167–80.
15.
ConnickPKolappanMCrawleyCWebberDJPataniRMichellAW, and others. 2012. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol11(2):150–6.
16.
DavidSKronerA. 2011. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci12(7):388–99.
17.
EdalatHHajebrahimiZPirhajatiVMovahedinMTavallaeiMSoroushMR, and others. 2013. Transplanting p75-suppressed bone marrow stromal cells promotes functional behavior in a rat model of spinal cord injury. Iran Biomed J17(3):140–5.
18.
FerreiraAAPereiraMJManhaesACBarradasPC. 2007. Ultrastructural identification of oligodendrocyte/myelin proteins in corpus callosum of hypothyroid animals. Int J Dev Neurosci25(2):87–94.
19.
FitchMTSilverJ. 2008. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol209(2):294–301.
20.
ForostyakSJendelovaPSykovaE. 2013. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications. Biochimie95(12):2257–70.
21.
FranklinRJFfrench-ConstantC. 2008. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci9(11):839–55.
22.
FrisenJHaegerstrandARislingMFriedKJohanssonCBHammarbergH, and others. 1995. Spinal axons in central nervous system scar tissue are closely related to laminin-immunoreactive astrocytes. Neuroscience65(1):293–304.
23.
GenselJCDonnellyDJPopovichPG. 2011. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Expert Opin Ther Targets15(4):505–18.
24.
GimenezyRibottaMMenetVPrivatA. 2001. The role of astrocytes in axonal regeneration in the mammalian CNS. Prog Brain Res132:587–610.
25.
GuWZhangFXueQMaZLuPYuB. 2010. Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord. Neuropathology30(3):205–17.
26.
HailerNP. 2008. Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol84(3):211–33.
27.
HawrylukGWMotheAWangJWangSTatorCFehlingsMG. 2012. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev21(12):2222–38.
28.
HofstetterCPSchwarzEJHessDWidenfalkJEl ManiraAProckopDJ, and others. 2002. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A99(4):2199–204.
29.
HonmouOHoukinKMatsunagaTNiitsuYIshiaiSOnoderaR, and others. 2011. Intravenous administration of auto serumexpanded autologous mesenchymal stem cells in stroke. Brain134(Pt 6):1790–807.
30.
HonmouOOnoderaRSasakiMWaxmanSGKocsisJD. 2012. Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol Med. 18(5):292–7.
31.
HuangWVodovotzYKusturissMBBarclayDGreenwaldKBoningerML, and others. 2013. Identification of distinct monocyte phenotypes and correlation with circulating cytokine profiles in acute response to spinal cord injury: a pilot study. PM R. Epub October17. doi:10.1016/j.pmrj.2013.10.006.
32.
JakovcevskiIFilipovicRMoZRakicSZecevicN. 2009. Oligodendrocyte development and the onset of myelination in the human fetal brain. Front Neuroanat3:5.
33.
JeongSWChuKJungKHKimSUKimMRohJK. 2003. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke34(9):2258–63.
34.
JiangXXZhangYLiuBZhangSXWuYYuXD, and others. 2005. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood105(10):4120–6.
35.
KalininaNISysoevaVYRubinaKAParfenovaYVTkachukVA. 2011. Mesenchymal stem cells in tissue growth and repair. Acta Naturae3(4):30–7.
36.
KangESHaKYKimYH. 2012. Fate of transplanted bone marrow derived mesenchymal stem cells following spinal cord injury in rats by transplantation routes. J Korean Med Sci27(6):586–93.
37.
KaramouzianSNematollahi-MahaniSNNakhaeeNEskandaryH. 2012. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. Clin Neurol Neurosurg114(7):935–9.
38.
KaraozEKabatasSDuruksuGOkcuASubasiCAyB, and others. 2012. Reduction of lesion in injured rat spinal cord and partial functional recovery of motility after bone marrow derived mesenchymal stem cell transplantation. Turk Neurosurg22(2):207–17.
39.
Karimi-AbdolrezaeeSBillakantiR. 2012. Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Mol Neurobiol46(2):251–64.
40.
KarussisDKarageorgiouCVaknin-DembinskyAGowda-KurkalliBGomoriJMKassisI, and others. 2010. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophiclateral sclerosis. Arch Neurol67(10):1187–94.
41.
KeilhoffGGoihlALangnaseKFansaHWolfG. 2006a. Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells. Eur J Cell Biol85(1):11–24.
42.
KeilhoffGStangFGoihlAWolfGFansaH. 2006b. Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination. Cell Mol Neurobiol26(7-8):1235–52.
43.
KhalatbaryARTiraihiT. 2009. A comparative study of therapeutic benefits of intraspinal and intravenous bone marrow stromal cell administration to spinal cord injuries. Iran Biomed J13:43–8.
44.
KigerlKAGenselJCAnkenyDPAlexanderJKDonnellyDJPopovichPG. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci29(43):13435–44.
45.
LeeJSHongJMMoonGJLeePHAhnYHBangOY, and others. 2010. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells28(6):1099–106.
46.
LeeKHSuh-KimHChoiJSJeunSSKimEJKimSS, and others. 2007. Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats. Acta Neurobiol Exp (Wars)67(1):13–22.
47.
LiBCXuCZhangJYLiYDuanZX. 2012. Differing Schwann cells and olfactory ensheathing cells behaviors, from interacting with astrocyte, produce similar improvements in contused rat spinal cord’s motor function. J Mol Neurosci48(1):35–44.
48.
LopatinaTKalininaNKaragyaurMStambolskyDRubinaKRevischinA, and others. 2011. Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo. PLoS One6(3):e17899.
49.
LunnJSSakowskiSAFeldmanEL. 2014. Stem cell therapies for amyotrophic lateral sclerosis: Recent advances and prospects for the future. Stem Cells. Epub Jan 21. doi:10.1002/stem.1628.
50.
MartinezFOHelmingLGordonS. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol27:451–83.
51.
MartinezFOSicaAMantovaniALocatiM. 2008. Macrophage activation and polarization. Front Biosci. 13:453–61.
52.
MatisGKBirbilisTA. 2009. Erythropoietin in spinal cord injury. Eur Spine J18(3):314–23.
53.
MazziniLMareschiKFerreroIVassalloEOliveriGNasuelliN, and others. 2008. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci265(1-2):78–83.
54.
McTigueDMTripathiRB. 2008. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem. 107(1):1–19.
55.
MekhailMAlmazanGTabrizianM. 2012. Oligodendrocyte-protection and remyelination post-spinal cord injuries: a review. Prog Neurobiol96(3):322–39.
56.
MoritaEWatanabeYIshimotoMNakanoTKitayamaMYasuiK, and others. 2008. A novel cell transplantation protocol and its application to an ALS mouse model. Exp Neurol213(2):431–8.
57.
NakajimaHUchidaKGuerreroARWatanabeSSugitaDTakeuraN, and others. 2012. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma29(8):1614–25.
58.
NakanoNNakaiYSeoTBYamadaYOhnoTYamanakaA, and others. 2010. Characterization of conditioned medium of cultured bone marrow stromal cells. Neurosci Lett483(1):57–61.
59.
NeuhuberBTimothy HimesBShumskyJSGalloGFischerI. 2005. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res. 1035(1):73–85.
60.
O’BrienMFLenkeLGLouJBridwellKHJoyceME. 1994. Astrocyte response and transforming growth factor-beta localization in acute spinal cord injury. Spine (Phila Pa 1976)19(20):2321–9.
61.
OhtaMSuzukiYNodaTEjiriYDezawaMKataokaK, and others. 2004. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol187(2):266–78.
62.
OsakaMHonmouOMurakamiTNonakaTHoukinKHamadaH, and others. 2010. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res1343:226–35.
63.
ParkSILimJYJeongCHKimSMJunJAJeunSS, and others. 2012. Human umbilical cord blood-derived mesenchymal stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell proliferation and oligogenesis. J Biomed Biotechnol362473.
64.
ParrAMTatorCHKeatingA. 2007. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 40(7):609–19.
65.
PaulCSamdaniAFBetzRRFischerINeuhuberB. 2009. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine (Phila Pa 1976)34(4):328–34.
66.
PhinneyDGIsakovaI. 2005. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des. 11(10):1255–65.
67.
PonomarevEDMareszKTanYDittelBN. 2007. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci27(40):10714–21.
68.
PopovichPGGuanZMcGaughyVFisherLHickeyWFBassoDM. 2002. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J Neuropathol Exp Neurol61(7):623–33.
69.
QuertainmontRCantinieauxDBotmanOSidSSchoenenJFranzenR. 2012. Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One7(6):e39500.
70.
RismanchiNFloydCLBermanRFLyethBG. 2003. Cell death and long-term maintenance of neuron-like state after differentiation of rat bone marrow stromal cells: a comparison of protocols. Brain Res991(1-2):46–55.
71.
RubinaKKalininaNEfimenkoALopatinaTMelikhovaVTsokolaevaZ, and others. 2009. Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue Eng Part A15(8):2039–50.
72.
SaijoKGlassCK. 2011. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol11(11):775–87.
73.
SaitoFNakataniTIwaseMMaedaYMuraoYSuzukiY, and others. 2012. Administration of cultured autologous bone marrow stromal cells into cerebrospinal fluid in spinal injury patients: a pilot study. Restor Neurol Neurosci30(2):127–36.
74.
SasakiMHonmouOAkiyamaYUedeTHashiKKocsisJD. 2001. Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia35(1):26–34.
75.
SchwartzMYolesE. 2006. Immune-based therapy for spinal cord repair: autologous macrophages and beyond. J Neurotrauma23(3-4):360–70.
76.
SharpJFrameJSiegenthalerMNistorGKeirsteadHS. 2010. Human embryonic stem cell–derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells28(1):152–63.
77.
ShinTAhnMMoonCKimSSimKB. 2013. Alternatively activated macrophages in spinal cord injury and remission: another mechanism for repair?Mol Neurobiol47(3):1011–9.
78.
SofroniewMVVintersHV. 2010. Astrocytes: biology and pathology. Acta Neuropathol119(1):7–35.
79.
TomVJHouleJD. 2008. Intraspinal microinjection of chondroitinase ABC following injury promotes axonal regeneration out of a peripheral nerve graft bridge. Exp Neurol. 211(1):315–9.
80.
Torres-EspinAHernandezJNavarroX. 2013. Gene expression changes in the injured spinal cord following transplantation of mesenchymal stem cells or olfactory ensheathing cells. PLoS One8(10):e76141.
81.
UrdzikovaLJendelovaPGlogarovaKBurianMHajekMSykovaE. 2006. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma23(9):1379–91.
82.
VaqueroJZuritaM. 2011. Functional recovery after severe CNS trauma: current perspectives for cell therapy with bone marrow stromal cells. Prog Neurobiol93(3):341–9.
WrightKTEl MasriWOsmanAChowdhuryJJohnsonWE. 2011. Concise review: bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications. Stem Cells29(2):169–78.
85.
WrightKTEl MasriWOsmanARobertsSChamberlainGAshtonBA, and others. 2007. Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A. Biochem Biophys Res Commun354(2):559–66.
86.
WuSSuzukiYEjiriYNodaTBaiHKitadaM. 2003. Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. J Neurosci Res. 72(3):343–51.
87.
WuXRenJLiJ. 2012. Fibrin glue as the cell-delivery vehicle for mesenchymal stromal cells in regenerative medicine. Cytotherapy14(5):555–62.
88.
YongVWRivestS. 2009. Taking advantage of the systemic immune system to cure brain diseases. Neuron64(1):55–60.
89.
ZhukarevaVObrockaMHouleJDFischerINeuhuberB. 2010. Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli. Cytokine50(3):317–21.
90.
ZuritaMVaqueroJBonillaCSantosMDe HaroJOyaS, and others. 2008. Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells. Transplantation86(6):845–53.
